Since OLIG2 is also a key transcription factor required to reprogram differentiated glioma cells into highly tumorigenic glioma stem cells26, in the future it will be worth investigating whether anticancer drugs lead to a modification of the cell identity in human high-grade glioma. The gene discussed is OLIG2; the disease is central nervous system cancer.